Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is -11.88% lower on its value in year-to-date trading and has touched a low of $99.06 and a high of $143.32 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The JAZZ stock was last observed hovering at around $108.64 in the last trading session, with the day’s loss setting it -0.25%.
Currently trading at $108.39, the stock is -3.81% and -1.14% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.97 million and changing -0.23% at the moment leaves the stock -6.04% off its SMA200. JAZZ registered -21.99% loss for a year compared to 6-month loss of -7.51%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -2.68% gain in the last 1 month and extending the period to 3 months gives it a 1.70%, and is -6.86% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.30% over the week and 2.31% over the month.
Jazz Pharmaceuticals plc (JAZZ) has around 2800 employees, a market worth around $6.69B and $3.91B in sales. Current P/E ratio is 19.36 and Fwd P/E is 5.03. Profit margin for the company is 10.10%. Distance from 52-week low is 9.42% and -24.37% from its 52-week high. The company has generated returns on investments over the last 12 months (4.42%).
The EPS is expected to grow by 6.83% this year
683.0 institutions hold shares in Jazz Pharmaceuticals plc (JAZZ), with institutional investors hold 99.11% of the company’s shares. The shares outstanding are 62.26M, and float is at 59.64M with Short Float at 3.41%. Institutions hold 96.25% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 6.32 million shares valued at $674.82 million. The investor’s holdings represent 10.1103 of the JAZZ Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 6.15 million shares valued at $655.94 million to account for 9.8274 of the shares outstanding. The other top investors are LSV ASSET MANAGEMENT which holds 2.48 million shares representing 3.9666 and valued at over $264.75 million, while CAPITAL WORLD INVESTORS holds 3.2294 of the shares totaling 2.02 million with a market value of $215.55 million.
Jazz Pharmaceuticals plc (JAZZ) Insider Activity
Still, SEC filings show that on Aug 06 ’24, Smith Mark Douglas (Director) Proposed Sale 3,075 shares at an average price of $111.00 for $0.34 million. The insider now directly holds shares of Jazz Pharmaceuticals plc (JAZZ).
